Scribe Therapeutics, co-founded by Jennifer Doudna, is reducing staff, the latest layoffs among companies focused on CRISPR ...

Health insurers like UnitedHealth are under tremendous public scrutiny for tactics such as prior authorization and care ...

Jimmy Carter’s example — as a leader, a humanitarian, and a human — can guide us through these unclear times, writes WHO ...

The White House gives agencies more leeway with one of the few tools against meth use: financial incentives, or "contingency ...

Transcarent CEO Glen Tullman spent much of 2024 hinting that his health benefits upstart might be shopping around for ...

He also articulated a very specific doctrine about the role of an FDA commissioner, one that is limited in its power and ...

In an interview, outgoing FDA commissioner Robert Califf was wary of the Trump administration but unapologetic about ...

The beleaguered Belgian firm Galapagos is splitting itself into two companies, with the brandname biotech prioritizing ...

The drug industry is facing one of the largest patent cliffs in recent history. Will that mean dealmaking at the annual J.P.

The Beckman Foundation wanted to make sure it wasn’t unfairly prioritizing elite research institutions. So it tried something ...

Tenvie Therapeutics is making hay from an R&D shift at Denali Therapeutics, acquiring several of its neuroscience drug ...

Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.